October 2, 2023
October 2, 2023 - Novo Nordisk announced the U.S. Food and Drug Administration has
approved Rivfloza TM (nedosiran) injection 80 mg, 128 mg, or 160 mg
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global healthcare
September 29, 2023
September 29, 2023 – KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A of Betaxolol
September 29, 2023
September 29, 2023 - Biogen Inc. announced that the U.S. Food and Drug Administration has
approved Tofidence (tocilizumab-bavi) intravenous formulation
September 28, 2023
September 28, 2023 - Amicus Therapeutics announced that the U.S. Food and Drug Administration has approved PombilitiTM (cipaglucosidase alfa-atga)
September 28, 2023
Sept. 28, 2023 - Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer) announced that the U.S. Food and Drug
Administration has approved Exxua (gepirone hydrochloride extended-release
September 27, 2023
September 27, 2023 - Scynexis, Inc. is conducting a voluntary nationwide recall of 2 lots of BREXAFEMME®
September 27, 2023
Sept. 27, 2023 - Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company and Viatris
Inc., announced that the U.S. Food and Drug Administration
September 27, 2023
October 27, 2023 - Coherus BioSciences, Inc. and Shanghai Junshi Biosciences Co., Ltd. have announced
that the U.S. Food and Drug Administration (FDA) approved LoqtorziTM